Although we aimed to investigate the effects of altered glia–neuron communication and therefore focused on AD‐risk gene‐associated targets in receivers, we also noticed that four of 23 ligand–receptor pairs had either a ligand (Calm2) or receptor (App) that was in the AD‐risk gene set. The gene discussed is CALM2; the disease is Alzheimer disease.